跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Brezofree 250 Synchrobreathe SB - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Brezofree 250 Synchrobreathe SB
Approved
STANDARD
Brezofree 250 Synchrobreathe SB
Cipla Limited (Unit II)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5703a1f22a005381
Company
Cipla Limited (Unit II)
Type
Standard
Approval Details
Approval Id
5703a1f22a005381
Drug Approval Philippines Name
Brezofree 250 Synchrobreathe SB
Product Name
Brezofree 250 Synchrobreathe SB
Registration Number
DRP-11324
Brand Name
Brezofree 250 Synchrobreathe SB
Generic Name
Salmeterol (as xinafoate) + Fluticasone Propionate
Dosage Form
Metered Dose Inhaler (Suspension)
Dosage Strength
25 mcg/250 mcg
Manufacturer
Cipla Limited (Unit II)
Importer
RV Group Phil. Branch
Distributor
RV Group Phil. Branch
Issuance Date
24 June 2024
Expiry Date
02 March 2027
Pharmacologic Category
Anti-asthma (Adrenergic/Corticosteriod)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5703a1f22a005381
Type
Standard
Back to Philippines FDA Approvals